1.赵峻, 向阳, 万希润, 等. 胎盘部位滋养细胞肿瘤的临床病理特征及预后分析. 中华医学杂志, 2006, 86 (27):1922-1924.

2. Baergen RN, Rutgers JL, Young RH, et al. Placental site trophoblastic tumor: A study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol, 2006, 100 (3): 511-520.

3.Burton JL, Lidbury EA, Gillespie AM, et al. Overdiagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology, 2001, 38 (5): 409-417.

4.Buza N, Baine I, Hui P. Precision genotyping diagnosis of lung tumors with trophoblastic morphology in young women. Mod Pathol, 2019, 32 (9): 1271-1280.

5.Bynum J, Murphy KM, DeScipio C, et al. Invasive complete hydatidiform moles: Analysis of a case series with genotyping. Int J Gynecol Pathol, 2016, 35 (2): 134-141.

6.Chan HY, Siu MK, Zhang HJ, et al. Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices. Histopathology, 2008, 53 (2): 139-146.

7.Chan KK, Wong ES, Wong IT, et al. Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma. BMC Cancer, 2019, 19(1): 953.

8.Cheung AN, Chan KK. Perplexing hCG profile after evacuation of hydatidiform mole. Lancet, 2012, 379(9811): 98-100.

9.Cheung AN, Sit AS, Chung LP, et al. Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. Gynecol Oncol, 1994,55 (3 Pt 1): 386-392.

10.Cheung AN, Zhang HJ, Xue WC, et al. Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future Oncol, 2009, 5 (2): 217-231.

11.Cheung AN. Gestational Trophoblastic Disease. In: Robboy S, Russel P, Mutter G (eds). Pathology of the Female Reproductive Tract, Vol., 2009: 881-907.

12.Chiu PM, Liu VW, Ngan HY, et al. Detection of mitochondrial DNA mutations in gestational trophoblastic disease. Hum Mutat, 2003, 22 (2): 177.

13.Chu MMY, Tse KY, Chan KKL, et al. Placental Site Trophoblastic Tumor: A Distinct Entity of Gestational Trophoblastic Disease Experience from a Tertiary Referral Center in Hong Kong. J Reprod Med. 2016 Aug; 61 (7-8): 351-356.

14.Feng HC, Tsao SW, Ngan HY, et al. Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study. Cancer, 2005, 104(11): 2409-2416.

15.Fong PY, Xue WC, Ngan HY, et al. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study. Cancer, 2005,103 (2): 268-276.

16.Fukunaga M, Katabuchi H, Nagasaka T, et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol, 2005, 29 (7): 942-947.

17.Fukunaga M. Immunohistochemical characterization of p57 (KIP2) expression in early hydatidiform moles. Hum Pathol, 2002, 33 (12): 1188-1192.

18.Gestational trophoblastic disease. In World Health Organization Classification of Tumours 5th Edition-Female Genital Tumours. IARC press: Lyon, 2020 (In press).

19.Hui P. Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology. Arch Pathol Lab Med,2019, 143 (1): 65-74.

20.Khong TY. Chorangioma with trophoblastic proliferation. Virchows Arch, 2000, 436 (2): 167-171.

21.Lai CY, Chan KY, Khoo US, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol, 2004, 17 (1): 40-48.

22.Li J, Yang J, Liu P, et al. Clinical characteristics and prognosis of 272 postterm choriocarcinoma patients at Peking Union Medical College Hospital: a retrospective cohort study. BMC Cancer, 2016, 16: 347.

23.Lurain JR. Gestational trophoblastic disease I: ep idemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol, 2010, 203 (6): 531-539.

24.Mak VC, Lee L, Siu MK, et al. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome. Mod Pathol, 2011, 24 (4): 522-532.

25.Mak VC, Lee L, Siu MK, et al. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation. Carcinogenesis, 2013, 34 (9): 2170-2177.

26.Mak VC, Wong OG, Siu MK, et al. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling. Am J Pathol, 2015, 185 (7):2038-2048.

27.Mao TL, Kurman RJ, Jeng YM, et al. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol, 2008, 32 (2): 236-242.

28.McCluggage WG, Ashe P, McBride H, et al. Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology, 1998, 32 (3): 252-256.

29.Mello JB, Ramos Cirilo PD, Michelin OC, et al. Genomic profile in gestational and non-gestational choriocarcinomas. Placenta, 2017, 50: 8-15.

30.Messaed C, Chebaro W, Di Roberto RB, et al. NLRP7 in the spectrum of reproductive wastage: rare nonsynonymous variants confer genetic susceptibility to recurrent reproductive wastage. J Med Genet, 2011, 48 (8):540-548.

31.Ngan HYS, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet, 2018, 143 (Suppl 2):79-85.

32.Nguyen NM, Slim R. Genetics and Epigenetics of Recurrent Hydatidiform Moles: Basic Science and Genetic Counselling. Curr Obstet Gynecol Rep, 2014, 3:55-64.

33.Nguyen NM, Zhang L, Reddy R, et al. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation. J Med Genet, 2014, 51 (9): 623-634.

34.Nguyen NMP, Khawajkie Y, Mechtouf N, et al. The genetics of recurrent hydatidiform moles: new insights and lessons from a comprehensive analysis of 113 patients. Mod Pathol, 2018, 31 (7): 1116-1130.

35.Paradinas FJ, Sebire NJ, Fisher RA, et al. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology, 2001, 39 (5): 447-454.

36.Savage J, Adams E, Veras E, et al. Choriocarcinoma in women: Analysis of a case series with genotyping. Am J Surg Pathol, 2017, 41 (12): 1593-1606.

37.Sebire NJ, Lindsay I, Fisher RA, et al. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol, 2005, 24 (1): 21-29.

38.Shen DH, Khoo US, Ngan HY, et al. Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole. Arch Pathol Lab Med, 2003, 127 (7): e291-293.

39.Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol, 1998, 22 (11): 1393-1403.

40.Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol, 2001, 20 (1): 31-47.

41.Shih IM, Nesbit M, Herlyn M, et al. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4,on paraffin-embedded tissue. Mod Pathol, 1998, 11:1098-1106.

42.Siu MK, Wong ES, Chan HY, et al. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol, 2008, 173 (4): 1165-1172.

43. Stichelbout M, Devisme L, Franquet-Ansart H, et al. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor. Hum Pathol, 2016, 54:121-126.

44.Tse KY, Chiu KW, Chan KK, et al. A case series of five patients with pure or mixed gestational epithelioid trophoblastic tumors and a literature review on mixed tumors. Am J Clin Pathol, 2018, 150 (4): 318-332.

45. Wong SY, Ngan HY, Chan CC, et al. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol, 1999, 12 (11): 1025-1033.

46.Xue WC, Chan KY, Feng HC, et al. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn, 2004, 6 (4):326-334.

47.Xue WC, Guan XY, Ngan HY, et al. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer, 2002, 94 (8):2288-2294.

48.Young RH, Kurman RJ, Scully RE. Placental site nodules and plaques. A clinicopathologic analysis of 20 cases. Am J Surg Pathol, 1990, 14 (11): 1001-1009.

49.Zhang X, Yan K, Chen J, et al. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series. Diagn Pathol, 2019, 14 (1): 93.